MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A Device Agnostic Pipeline for Gait Detection and Assessment in Free-living and Clinical Environments

    B. Cornish, K. Beyer, K. Weber, A. Vert, K. van Ooteghem, W. Mcilroy (Waterloo, Canada)

    Objective: To provide a framework for a device agnostic gait analytics pipeline for standardizing and improving quantitative gait analysis using wearable sensors. Background: Gait impairments…
  • 2024 International Congress

    Artificial Intelligence Opportunities for Diagnostics of Dementia via Speech (Brainphone Project)

    I. Khasanov, D. Khasanova (Kazan, Russian Federation)

    Objective: The aim of the clinical study was the assessment of efficiency of the screening diagnositics method for dementia by speech using AI-based technology (BRAINPHONE…
  • 2024 International Congress

    Get Ready a mobile phone app a solution for patient engagement/remote management

    R. Mills, M. Gibbs, N. Pavese, D. Ledingham, A. Hussain, A. Jenkins, C. Nicholson (Newcastle, United Kingdom)

    Objective: The movement disorder DBS team at the Royal Victoria Infirmary, developed‘Get Ready®’ mobile phone app for patients who are candidates for DBS. The app…
  • 2024 International Congress

    Creating myPPMI: an Online Portal to Deliver Study Participant Content

    C. Stanley, J. Talarico, C. Fitzgerald, C. Destro, M. Mcguire Kuhl, J. Schulze, L. Heathers, E. Flagg, B. Mcmahon, T. Foroud, T. Tropea, K. Fabrizio, K. Marek (New Haven, USA)

    Objective: Building a centralized platform to collect patient reported outcomes and provide educational and informational content to participants Background: Patient portals are a valued healthcare…
  • 2024 International Congress

    Examining and contextualizing free-living heart rate using multiple wearable sensors: a potential approach for assessing autonomic dysfunction in Parkinson’s disease?

    FE. Godkin, K. van Ooteghem, K. Ehgoetz Martens, K. Weber, B. Cornish, K. Beyer, D. Olszewska, C. Fearon, A. Lang, R. Swartz, M. Masellis, B. Tan, J. Tung, A. Roberts, W. Mcilroy (Waterloo, Canada)

    Objective: To examine context-specific fluctuations in free-living heart rate (HR) across a week-long multi-sensor wear period in people with Parkinson’s disease (PD). Background: Non-motor symptoms,…
  • 2024 International Congress

    Use of social media and health information technology among caregivers of Alzheimer’s disease and other neurological conditions: Secondary analysis of the 2022 Health Information National Trend (HINTS) Survey

    M. Arbabi Kalati (Hinsdale, USA)

    Objective: This study aims to evaluate the pattern of health information seeking from social media and other health technology tools among caregivers for individuals with…
  • 2024 International Congress

    Artificial Intelligence and Visual Analysis of Movements in Parkinson’s Disease

    T. Okelberry, H. Beisar, S. Horev, E. Pinchuk, K. Lyons, R. Pahwa (Kansas City, USA)

    Objective: To evaluate the use of artificial intelligence in the analysis and classification of movements in Parkinson's disease. Background: Artificial intelligence (AI) is a powerful…
  • 2024 International Congress

    Long-term effects of Deep Brain Stimulation on gait and postural control in Parkinson’s disease

    S. Zheng, JL. Wu, SQ. Liang, Y. Yu, JC. Wu, HT. Li, YY. Cheng (tianjin, China)

    Objective: To investigate the effects of deep brain stimulation (DBS) on gait and postural control in patients with Parkinson's disease (PD) two years after surgery.…
  • 2024 International Congress

    Quantification of Neuroinflammation and White Matter Injury in Parkinson Disease Using Diffusion Basis Spectrum Imaging

    R. White Iii, J. Rutlin, B. Maiti, M. Campbell, J. Shimony, J. Perlmutter (Saint Louis, USA)

    Objective: To investigate differences in white matter (WM) using Diffusion Basis Spectrum Imaging (DBSI) between participants with Parkinson’s disease (PD) and controls and to examine…
  • 2024 International Congress

    First-In-Human Single and Multiple Ascending Dose Trial Design of LY3962681, a Novel Intrathecally Delivered siRNA Targeting α-synuclein mRNA for the Treatment of Patients with Parkinson’s Disease

    T. Lewis, B. Calamini, L. Verselis, M. Lowrey, L. Shaughnessy, J. Deranick, M. Dieter, M. Krautkramer, O. Uspenskaya, J. Sevigny (New York, USA)

    Objective: Development of a Phase 1 clinical trial evaluating LY3962681, a novel, intrathecally delivered siRNA directly targeting α-synucleinmRNA (SNCA) to reduce α-synuclein protein (ASYN), for the treatment of…
  • « Previous Page
  • 1
  • …
  • 454
  • 455
  • 456
  • 457
  • 458
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley